Indonesia healthcare market has shown a
positive incline during 2012-2017 but with respect to the expanding population
of Indonesia, the market is still underserved especially in the underdeveloped
and rural areas as of 2017. People across Indonesia are facing several health
care issues due to sedentary lifestyle and fast food consumption habits, such
as obesity, diabetes, and other cardiovascular diseases, which are demanding
for technologically advanced healthcare infrastructure. The Indonesia healthcare market has increased on the account of
increasing healthcare facilities, innovation in pharmaceutical manufacturers
and clinical laboratory services and expansion of pharmacy retail chains across
the country. The market has witnessed enhancing
innovation in nutritional health segment, biopharmaceuticals and specialty
pharmaceutical products.
Hospitals in the country contributed to the
maximum share of overall healthcare market as of 2016. Over ~% of the market
revenues were generated from the hospitals segment followed by the
pharmaceutical market with ~% in 2017.
Indonesia Healthcare market revenue has
increased from USD ~ billion in 2012 to USD ~ billion in 2017 primarily due to
rising prevalence of non-communicable and lifestyle diseases including
diabetes, asthma and heart disorders. The industry has undergone various
deregulation programs which has encouraged foreign investment in the industry. Furthermore,
increase in demand for generic medicines has led the major players in the
industry to expand their production capabilities.
Indonesia
Clinical Laboratory Market is in the growing stage. The market has grown at a
CAGR of ~% during 2012 to 2017 with revenue estimated at USD ~ billion in 2017.
The industry has witnessed expansion of private laboratory chains and use of
advanced technology in order to provide high quality laboratory services. With
the implementation of JKN, the demand for laboratory services has further
increased. The public hospitals mostly perform routine test while the esoteric
tests are outsourced to the private clinical laboratories. Due to growing awareness amongst people about
healthy living, private and public laboratories have witnessed an increase in
walk in patients asking for routine checkups which is funded out of the
patient’s pocket. Further, the major private laboratory chains have expanded
their operations in terms of capacity and geographic presence. The six major private
laboratories occupying ~% of the revenue share of Indonesia Private independent
labs in 2016 are Prodia, Kimia Farma, Pramita, Cito, Parahita and BioMedika.
The
public clinical labs have accounted for ~% of the revenue share in Indonesia
clinical laboratory market in 2017. Private hospital labs have accounted for ~%
in 2017 and private independent labs with ~% of the overall market. The
laboratory chains have been the leading market players in Indonesia in 2016
with ~% of revenue in the overall private independent laboratory market in
2016. Single independent labs have contributed to their lower revenue share of
~% due to their restricted geographic presence.
Doctor
Referrals have accounted for the largest share of ~% of the tests in Indonesia
Private independent laboratory market in 2016. With growing awareness about
chronic diseases and their treatment procedure increasing number of Indonesians
have taken charge of their own health. This has led to an increase in number of
walk-ins at medical laboratories which has registered ~% of the tests. This is
followed by corporate clients with ~% of the tests and external referrals with
~% of the total tests in 2016
Routine
tests have accounted for ~% of the revenue in Indonesia Private independent
laboratory market in 2016. This is followed by esoteric tests with ~% and non
laboratory tests with ~% of the overall private independent laboratory market. Esoteric tests require a professional
approach from highly-skilled technical personnel, often utilize more
sophisticated technology, equipment or materials and are generally ordered less
frequently than routine tests. Generally, margins for esoteric tests are higher
as compared to routine tests.
Java,
Sumatra, Bali, Jakarta and Palembang have together accounted for ~% of the
revenue in the overall private laboratory market in 2016. This is driven by
high rate of urbanization and more affluent population, which has created greater
demand for private clinical laboratory testing services. Underdeveloped cities
such as Sulawesi, Maluku and Kalimantan have together accounted for ~% of the
revenue in 2016.
The
UHC scheme has increased the demand for basic and specialized testing. Since
public clinical labs are not equipped with the technology for specialized
testing, such tests have been outsourced to private independent laboratories.
Rising major illness of NCDs and CDs has driven the demand for cardiovascular
tests, tumor markers, metabolic tests, malaria and TB tests. There has been an
increase in middle to high income earners seeking preventive health check-ups.
Health check-ups are driven by walk-in patients and corporate clients who have
together contributed up to 50% of the total test volume of a private
independent laboratory. In addition to this, it is expected that the number of
people taking health check-ups to grow by 2.2% on a yearly basis as more
emphasis is given to the promotion of preventive health checkups. Major laboratory
chains such as Cito, Pramita and Prodia have hence introduced health check up
packages for male, female, children, adolescents, and old age people. Further,
there are packages for different diseases such as cancer, diabetes, cardiac,
fertility and others. The market has witnessed introduction of wide range of
tests from routine tests to more specialized tests, including genomic platform
with multiplexing capabilities able to support different classes of patients
with precise diagnosis and speed up treatment consultation.
The
private independent clinical laboratory market is organized and is composed of
both chain laboratories and stand-alone laboratories. The chain laboratories
are the leading market players in Indonesia. The 6 major players in the
industry are Prodia, Kimia Farma, Pramita, Cito, BioMedika and Parahita. They
have together accounted for 71.2% of the revenue share in private independent
laboratory market in 2017. The major
players compete on distribution network, product portfolio, advertising,
technology, Prices and services
The
clinical laboratory market is expected to reach USD 3.2 billion by 2022 growing
at a CAGR of 11.5%. The major private independent laboratories chains are
expected to undergo geographic expansion beyond key cities into underdeveloped
areas. It is also expected that the implementation of JKN will increase the
demand for laboratory services. This will lead the public hospitals to refer
samples to private independent laboratories for clinical testing, resulting in
the growth of external referrals for private independent laboratories. Further,
the industry will witness a rising trend towards precision medicine also known
as personalized medicine. Further, the market for rapid tests will grow at a
CAGR of 13% between 2016 and 2021 in Indonesia. The growth will be driven by
factors such as increasing rate of infectious diseases such as dengue, malaria,
hepatitis, and HIV, the government’s healthcare initiatives, and product
advancements and innovations by rapid test manufacturers
Key
Topics covered in the report:-
Clinical Laboratory Market Size Indonesia
Number of Public Clinical Labs Indonesia
Number of Private Hospital Labs Indonesia
Number of Private Independent Labs Indonesia
Indonesia Clinical Laboratory value Chain
Market Share of Major Players in Indonesia Clinical
Laboratory Market
Number of Lab Tests in Indonesia
Major Laboratory Chains in Indonesia
Type of Customers in Indonesia Clinical Laboratory
Market
Major Type of Clinical Laboratory Tests Indonesia
Prodia Competitors Indonesia
Healthcare Spending Indonesia
Obese Population Indonesia
Indonesia Healthcare Market Future
Clinical Laboratory Market Future Trends Indonesia
Trends in Indonesia Clinical Laboratory Market
Issues & Challenges in Indonesia Clinical
Laboratory Market
Government Regulations in Indonesia Clinical
Laboratory market
Number of healthcare Centers in Indonesia
Budget Allocation on Healthcare Indonesia
Major Companies Clinical Laboratory Market
Indonesia
For
more information on the research report, refer to below link:
Related
Reports by Ken Research
Contact
:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-9015378249
No comments:
Post a Comment